A Sensitized IGF1 Treatment Restores Corticospinal Axon-Dependent Functions

Neuron. 2017 Aug 16;95(4):817-833.e4. doi: 10.1016/j.neuron.2017.07.037.

Abstract

A major hurdle for functional recovery after both spinal cord injury and cortical stroke is the limited regrowth of the axons in the corticospinal tract (CST) that originate in the motor cortex and innervate the spinal cord. Despite recent advances in engaging the intrinsic mechanisms that control CST regrowth, it remains to be tested whether such methods can promote functional recovery in translatable settings. Here we show that post-lesional AAV-assisted co-expression of two soluble proteins, namely insulin-like growth factor 1 (IGF1) and osteopontin (OPN), in cortical neurons leads to robust CST regrowth and the recovery of CST-dependent behavioral performance after both T10 lateral spinal hemisection and a unilateral cortical stroke. In these mice, a compound able to increase axon conduction, 4-aminopyridine-3-methanol, promotes further improvement in CST-dependent behavioral tasks. Thus, our results demonstrate a potentially translatable strategy for restoring cortical dependent function after injury in the adult.

Keywords: 4-aminopyridine; IGF1; axon regeneration; axon sprouting; ischemic stroke; osteopontin; spinal cord injury.

MeSH terms

  • Age Factors
  • Aminopyridines / pharmacology
  • Animals
  • Axotomy
  • Disease Models, Animal
  • Functional Laterality
  • Hindlimb / physiopathology
  • Insulin-Like Growth Factor I / pharmacology
  • Insulin-Like Growth Factor I / therapeutic use*
  • Mice
  • Movement Disorders / drug therapy
  • Movement Disorders / etiology
  • Neurons / drug effects*
  • Osteopontin / pharmacology
  • Osteopontin / therapeutic use*
  • Psychomotor Performance / drug effects
  • Psychomotor Performance / physiology
  • Pyramidal Tracts / pathology*
  • Recovery of Function / drug effects*
  • Recovery of Function / physiology
  • Reflex / drug effects
  • Reflex / genetics
  • Serotonin / metabolism
  • Spinal Cord Injuries / drug therapy*
  • Stroke / drug therapy
  • Time Factors

Substances

  • Aminopyridines
  • Osteopontin
  • Serotonin
  • Insulin-Like Growth Factor I
  • 4-aminopyridine methiodide